Literature DB >> 31097257

Ovarian hyperstimulation syndrome: A review for emergency clinicians.

Douglas Timmons1, Tim Montrief2, Alex Koyfman3, Brit Long4.   

Abstract

INTRODUCTION: A great deal of literature has recently evaluated the prevention and management of ovarian hyperstimulation syndrome (OHSS) in the outpatient setting, but there remains a dearth of research evaluating OHSS in the emergency department (ED) and its management.
OBJECTIVE: This narrative review evaluates the underlying pathophysiology and clinical manifestations of OHSS and discusses approaches to patient care in the ED based on current literature. DISCUSSION: OHSS is an iatrogenic complication caused by an excessive response to controlled ovarian stimulation during assisted reproductive cycles (ART). OHSS complicates up to 30% of ART cycles, and many of these patients seek initial care in the ED. Risk factors for the development of OHSS include age < 35, history of polycystic ovarian syndrome or previous OHSS, and pregnancy. Emergency physicians will be faced with several complications including ascites, abdominal compartment syndrome, renal dysfunction, acute respiratory distress syndrome, thromboembolic disease, and hemodynamic instability. Critical patients should be evaluated in the resuscitation bay, and consultation with the primary obstetrics/gynecology team is needed, which improves patient outcomes. This review provides several guiding principles for management of OHSS and associated complications.
CONCLUSIONS: OHSS occurs in up to 30% of IVF cycles and carries a high morbidity. Effective care of the OHSS patient begins with early diagnosis while evaluating for other diseases and complications. Understanding these complications and an approach to the management of OHSS is essential to optimizing patient care. Published by Elsevier Inc.

Entities:  

Keywords:  Ascites; Assisted reproductive technology; Effusion; Obstetrics; Ovarian hyperstimulation syndrome

Mesh:

Year:  2019        PMID: 31097257     DOI: 10.1016/j.ajem.2019.05.018

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  12 in total

1.  Assessing the Usefulness of Severity Markers in Women with Ovarian Hyperstimulation Syndrome.

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova
Journal:  Reprod Sci       Date:  2020-10-15       Impact factor: 3.060

2.  Ovarian hyperstimulation syndrome as a cause of acute limb ischemia.

Authors:  Paige Williams; Clifford Buckley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-15

3.  Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova; Batsunova Mariia Olegovna
Journal:  BMC Womens Health       Date:  2022-05-10       Impact factor: 2.742

4.  Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?

Authors:  Eryn Sara Rubenfeld; Michael Haim Dahan
Journal:  Obstet Gynecol Sci       Date:  2021-06-09

5.  Maternal-Perinatal Variables in Patients with Severe Preeclampsia Who Develop Acute Kidney Injury.

Authors:  Patrocinio Rodríguez-Benitez; Irene Aracil Moreno; Cristina Oliver Barrecheguren; Yolanda Cuñarro López; Fátima Yllana; Pilar Pintado Recarte; Coral Bravo Arribas; Melchor Álvarez-Mon; Miguel A Ortega; Juan A De Leon-Luis
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

6.  Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome.

Authors:  Jingjing Jiang; Shanshan Gao; Ting Han
Journal:  Comput Math Methods Med       Date:  2022-07-14       Impact factor: 2.809

7.  Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment.

Authors:  Yali Liu; Jiaying Lin; Li Chen; Xiaoyan Mao; Li Wang; Qiuju Chen; Sha Yu; Yanping Kuang
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

8.  Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles.

Authors:  Ivan Madrazo; Monserrat Fabiola Vélez; Josue Jonathan Hidalgo; Ginna Ortiz; Juan José Suárez; Leonardo M Porchia; M Elba Gonzalez-Mejia; Esther López-Bayghen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

Review 9.  Spontaneous ovarian hyperstimulation syndrome in a nonpregnant female patient: a case report and literature review.

Authors:  Wei Chai; Hongyu He; Fei Li; Wenlei Zhang; Chao He
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

10.  Effects of controlled ovarian stimulation on vascular barrier and endothelial glycocalyx: a pilot study.

Authors:  Nikolai Hulde; N Rogenhofer; M Rehm; C Thaler; F Brettner; N C Eckert; I Fetz; J-I Buchheim; T Kammerer; A Dendorfer; A Choukèr; K F Hofmann-Kiefer
Journal:  J Assist Reprod Genet       Date:  2021-07-20       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.